Compare · AMT vs SBRA
AMT vs SBRA
Side-by-side comparison of American Tower Corporation (REIT) (AMT) and Sabra Health Care REIT Inc. (SBRA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AMT and SBRA operate in Real Estate Investment Trusts (Real Estate), so they compete in similar markets.
- AMT is the larger of the two at $83.21B, about 15.6x SBRA ($5.32B).
- SBRA has been more active in the news (4 items in the past 4 weeks vs 3 for AMT).
- Both have 25 recent analyst ratings on file.
- Company
- American Tower Corporation (REIT)
- Sabra Health Care REIT Inc.
- Price
- -
- -
- Market cap
- $83.21B
- $5.32B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Real Estate Investment Trusts
- Real Estate Investment Trusts
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 3
- 4
- Recent ratings
- 25
- 25
American Tower Corporation (REIT)
American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of approximately 181,000 communications sites.
Sabra Health Care REIT Inc.
As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing - LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing - ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing - Managed communities. As of September 30, 2020, Sabra's real estate properties held for investment included 42,378 beds/units and its unconsolidated joint venture included 7,056 beds/units, spread across the United States and Canada.
Latest AMT
- Director Kalathur Rajesh bought $500,733 worth of shares (2,829 units at $177.00), increasing direct ownership by 57% to 7,765 units (SEC Form 4)
- American Tower upgraded by Barclays with a new price target
- American Tower to Present at the TD Cowen 12th Annual Communications Infrastructure Summit
- SVP & Advisor to the CFO Meyer Robert Joseph sold $894,450 worth of shares (5,000 units at $178.89), decreasing direct ownership by 19% to 21,428 units (SEC Form 4)
- EVP, Chief Admin Ofr, GC & Sec Dowling Ruth T sold $309,641 worth of shares (1,791 units at $172.89) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 27,711 units (SEC Form 4)
- SEC Form 10-Q filed by American Tower Corporation (REIT)
- American Tower Corporation (REIT) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- American Tower Corporation Reports Second Quarter 2026 Financial Results
- Harbor Link Deploys Underground Fiber into CoreSite DC2 Data Center, Expanding Carrier Diversity in Washington, D.C. and Northern Virginia
- American Tower upgraded by Wolfe Research with a new price target
Latest SBRA
- Sabra Health Care REIT upgraded by Raymond James
- SEC Form 10-Q filed by Sabra Health Care REIT Inc.
- Sabra Health Care REIT Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance
- Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Report
- Sabra Health Care REIT Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Sabra Issues Business Update and Increases Full-Year 2026 Guidance
- Sabra Health Care REIT, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call
- Sabra Health Care REIT downgraded by Truist
- Barclays initiated coverage on Sabra Health Care REIT with a new price target